Previous studies have suggested that the Pseudomonas aeruginosa PAK pilus adhesin moiety resides in an epithelial cell-binding domain located in the C-terminal region of the PAK pilin structural protein. Synthetic peptides Acl7red (a synthetic peptide with a sequence identical to that of PAK pilin residues 128 to 144, with the Cys-129 and Cys-142 residues being in the reduced state) and Acl7ox (a synthetic peptide with a sequence identical to that of PAK pilin residues 128 to 144, with a formed disulfide bridge between the amino acid residues Cys-129 and Cys-142), which should contain the epithelial cell-binding domain, were synthesized. Acl7red and Acl7ox both bound to buccal epithelial cells (BECs) Pseudomonas aeruginosa respiratory infections continue to constitute a significant source of morbidity and mortality for intubated intensive care unit patients (6, 10) and cystic fibrosis patients (26). P. aeruginosa infections are thought to be initiated upon adherence of the organism to, and subsequent colonization of, the respiratory epithelium (11, 12, 29) . Following the colonization of the respiratory mucosal surface, a descending-infection mechanism leads to the development of a pulmonary infection (25, 27) . P. aeruginosa can use both pili and alginate (the principle component of the P. aeruginosa capsule) as adhesins to mediate attachment to human respiratory epithelial cells (3, 4, 17, 23, 24, 30) . The pilus adhesin probably mediates the initial adherence of P. aeruginosa to the respiratory epithelial surface, because the pilus adhesin is considerably more effective than the alginate adhesin in mediating adherence (3, 4, 19, 20) . Characterization of the P. aeruginosa pilus adhesin may thus lead to a better understanding of the initiation of P. aeruginosa respiratory infections.
Pseudomonas aeruginosa respiratory infections continue to constitute a significant source of morbidity and mortality for intubated intensive care unit patients (6, 10) and cystic fibrosis patients (26) . P. aeruginosa infections are thought to be initiated upon adherence of the organism to, and subsequent colonization of, the respiratory epithelium (11, 12, 29) . Following the colonization of the respiratory mucosal surface, a descending-infection mechanism leads to the development of a pulmonary infection (25, 27) . P. aeruginosa can use both pili and alginate (the principle component of the P. aeruginosa capsule) as adhesins to mediate attachment to human respiratory epithelial cells (3, 4, 17, 23, 24, 30) . The pilus adhesin probably mediates the initial adherence of P. aeruginosa to the respiratory epithelial surface, because the pilus adhesin is considerably more effective than the alginate adhesin in mediating adherence (3, 4, 19, 20) . Characterization of the P. aeruginosa pilus adhesin may thus lead to a better understanding of the initiation of P. aeruginosa respiratory infections.
The exact nature of the P. aeruginosa pilus adhesin is not known, although the available evidence suggests that, unlike the P pilus and type I pilus of Escherichia coli (1, 13, 15, 16) , the pilin structural subunit functions as the actual adhesin. P. aeruginosa PAK pilin appears to contain an epithelial cell-binding domain because native peptides derived from the C-terminal end of the PAK pilin structural protein and synthetic peptides with an identical sequence significantly affect P. aeruginosa binding to human buccal epithelial cells (BECs) (4, 22) . These C-terminal peptides enhanced bacte-rial binding, possibly because of the two hydrophilic domains within the peptides, one domain interacting with the pilin subunit and one interacting with the BEC receptor. The peptide would thus act as a high-affinity bridge that would enhance binding. Additionally, monoclonal antibodies specific for the C-terminal end of pilin inhibit P. aeruginosa adherence to (2, 21) . Pili from PAK were purified as previously described (21) .
Peptide synthesis. Synthetic peptides Acl7red (a synthetic peptide with a sequence identical to that of PAK pilin residues 128 to 144, with the Cys-129 and Cys-142 residues being in the reduced state) and Acl7ox (a synthetic peptide with a sequence identical to that of PAK pilin residues 128 to 144, with a formed disulfide bridge between the amino acid residues Cys-129 and Cys-142) were prepared as previously described (4) . Ac17 cysteine residues were oxidized to form the intrachain disulfide bridge (Acl7ox) by the method of Hodges et al. (9) , and the formation of the disulfide bridge was verified on the basis of circular dichroism spectra by the method of Matsoukas et al. (18) .
BECs. BECs were collected with wooden applicator sticks from healthy, nonsmoking male volunteers (n = 10). BECs were removed from the applicator sticks by gentle agitation in phosphate-buffered saline (PBS), pH 7.2. The BECs were washed three times (2,000 x g for 10 min at 4°C) with PBS and then passed through a 70-,um-pore-size nylon mesh. The cell concentration for the BECs was determined with a hemacytometer and was adjusted to 2.0 x 105/ml. TEC preparation. Human ciliated TECs were obtained from patients in the surgical intensive care unit at Toronto General Hospital by bronchoscopic brushing of the bronchial mucosa by the method of Franklin et al. (5) . All procedures were approved by the Toronto General Hospital Ethics Committee, and informed consent was obtained from the relatives of the patients.
TECs were fixed with 1% formaldehyde in PBS for 1 h at room temperature. The cells were then washed twice with PBS and resuspended in PBS. TECs were counted with a hemacytometer, the TEC concentration was adjusted to 105/ml, and the formaldehyde-fixed cells were then used directly.
Ac17 binding to BECs. An immunoassay was performed to assess the binding of Acl7red and Acl7ox to BECs. BECs (0.2 ml at 2.0 x 105/ml) were added to an equal volume of synthetic peptide (0 to 120 nmol/ml) in PBS and incubated at 37°C and were then agitated at 300 rpm. After 1 h, BECs were collected by centrifugation (13,000 x g for 2 min at room temperature) and washed five times with PBS. Monoclonal antibody PK99H (0.2 ml of a 10-' dilution [in PBS] of purified immunoglobulin G [IgG] with a titer of 106) was added to the BEC pellet and incubated, as described above, for 1 h. The BECs were then collected by centrifugation (13,000 x g for 2 min at room temperature) and washed five times with PBS. Goat anti-mouse heavy and light chain [IgG(H+L)] immunoglobulin G-peroxidase conjugate (Jackson Laboratories) was added to the BEC pellet (0.2 ml of a 1:10,000 dilution in PBS), and the mixture was incubated, as described above, for 1 h. The BECs were collected by centrifugation (13,000 x g for 2 min at room temperature) and washed five times with PBS. The pellet was then suspended in 0.2 ml of 1 mM 2,2'-azino-di-(3-ethylbenzthiazoline sulfonic acid) in citrate buffer (pH 4.2) plus 0.03% (wt/vol) peroxide and transferred to a clean tube. The horseradish peroxidase enzyme reaction was stopped by the addition of 0.2 ml of 4 mM NaN3, and the optical density at 405 nm was determined after removal of the BECs by centrifugation. The BEC concentration in each tube was determined with a hemacytometer at the end of the assay, prior to the removal of BECs by centrifugation.
Ac17 inhibition of pilus binding to BECs. An immunoassay was performed to assess the effect of Acl7red on pilus binding to BECs. BECs (0.2 ml at 2.0 x 105/ml) and synthetic peptide Acl7red (0.1 ml such that a final concentration of 0, 40, 80, or 120 nmol of synthetic peptide per ml was obtained) were preincubated for 30 min at room temperature. Pili (0.1 ml at 0 to 100 ,ug/ml) were then added to the BECs with various concentrations of synthetic peptide (0, 40, 80, or 120 nmol/ml). The mixtures were then incubated for 2 h at 37°C while being agitated at 300 rpm. BECs and bound pili were then collected by centrifugation (13,000 x g for 2 min) and washed five times with PBS to remove unbound pili. Monoclonal antibody PK3B (0.1 ml of a 10-4 dilution in PBS) (this antibody recognizes PAK pili but does not react with synthetic peptide Acl7red [Doig et al., in press]) was then added to the BECs with bound pili and incubated for 1 h, as described above. The remainder of the immunoassay was the same as that described for pilus binding to BECs.
Pilus and Ac17 binding to TECs. TECs (0.1 ml at 105/ml) were mixed with an equal volume of PAK pili (345 ,ug/ml), thetic peptide) was incubated with the blot at 37°C for 1 (31) . Oxidation-reduction of the BEC glycoproteins was performed on preblocked blots. Blots were assessed for synthetic peptide binding as described above.
RESULTS
Binding of Acl7red and Acl7ox to BECs. Synthetic peptides Acl7ox and Acl7red both bound to BECs in a concentration-dependent manner (Fig. 1) . Saturation of binding of the synthetic peptide Acl7ox to BECs appeared to occur at a concentration of -30 nmol/ml, but the binding of the Acl7red synthetic peptide to BECs did not saturate under our experimental conditions (Fig. 1) . K I . e J ; ; , " ' . . s : ' ' and Acl7red (C and D) to human ciliated TECs. Panels E and F are control preparations not exposed to the synthetic peptides but exposed to monoclonal antibody PK99H and fluorescein isothiocyanate-conjugated anti-mouse IgG. Panels A, C, and E are phase-contrast micrographs of the same cells visualized by immunofluorescence microscopy in panels B, D, and F. Note that synthetic peptides Acl7ox and Acl7red both bind primarily to the cilia and the luminal portion of the cytoplasmic membrane of TECs. The apparent limited binding of Acl7ox to the TECs is the result of the lesser affinity of monoclonal antibody PK99H for the oxidized form of the peptide relative to the reduced form of the peptide.
binding to BECs by synthetic peptide Acl7red was examined by using a modified Lineweaver-Burk plot. The presence of the synthetic peptide resulted in a significant change in the Km of pilus binding to BECs (P < 0.05), while the changes in the apparent Vnax of pilus binding to BECs were not significant (P > 0.05) ( Table 1 ). The Lineweaver-Burk plot thus exhibited a pattern of inhibition that is typical of competitive inhibition (Fig. 2) .
Identification of BEC synthetic peptide receptors. PAK pili (lane 1 in Fig. 3 ) were observed to bind to BEC glycoprotein bands with approximate molecular masses of 82, 55 to 51, and 40 kilodaltons. The synthetic peptide Acl7red was observed to bind identical BEC glycoprotein bands, and the amount of synthetic peptide that bound to the BEC glycoprotein bands was found to decrease in a concentrationdependent manner (Fig. 3) as the peptide concentration was INFECT. IMMUN. 1. ll. The receptor activity of these glycoproteins was eliminated by one cycle of periodate oxidation followed by borohydride reduction (lanes 6 and 7 of Fig. 3 have been periodate oxidized and borohydride reduced; lane 6 was incubated with PAK pili, while lane 7 was not). Preincubation of the synthetic peptide Acl7red with Fab fragments of monoclonal antibody PK99H (which binds to the epithelial cellbinding domain) was found to inhibit the binding of synthetic peptide to the BEC proteins (lane 8 in Fig. 3 ), while preincubation of the peptide with Fab fragments of the monoclonal antibody PK41C (PK41C does not bind to Acl7red, but it is of the same IgG subclass as PK99H and it does bind to PAK pilin) as a control did not inhibit the binding of the peptide to the BEC glycoproteins (lane 9 in Fig. 3 ). Localization of pilus and synthetic peptide binding on TECs. The binding of PAK pili, synthetic peptide Acl7red, and synthetic peptide Acl7ox to formaldehyde-fixed human TECs was examined by indirect immunofluorescence. PAK pili were observed to bind primarily to the luminal portion of the cytoplasmic membrane and the basal two-thirds of the cilia of TECs (Fig. 4) . Very limited binding of PAK pili to other regions of the TECs was observed. Synthetic peptides Acl7red (Fig. 5a and b) and Acl7ox ( Fig. Sc and d) were also observed to bind to the luminal portion of the cytoplasmic membrane and the basal two-thirds of the cilia of the TECs. The localization patterns of PAK pilus, Acl7red, and Ac17ox binding to TECs were indistinguishable.
DISCUSSION
The P. aeruginosa pilus adhesin appears to play a significant role in the initiation of a number of infections (7, 8, 26, 29) . Our previous studies have suggested that PAK pilin has an epithelial cell-binding domain in the C-terminal region of the protein ( (Fig. 2) , indicating that pili and the synthetic peptide Acl7red bind to the same sites on the surface of the BECs.
It is likely that there are differences in the conformation of the Acl7ox-and PAK pilus-binding domains since the intact pilus has a Km of 16.4 mg/liter (or -0.01 ,uM, assuming that the average pilus has a molecular weight of 106), compared with a Km of 6.4 ,uM for Acl7ox. It is possible that the differences in the affinities result from a number of epithelial cell-binding domains being exposed at the tip of an intact pilus.
Synthetic peptide and pilus binding to BEC replicas and TECs. Putative BEC receptors to which Acl7red binds were identified by using BEC proteins immobilized on a nitrocellulose membrane. A number of glycoproteins were found to bind Acl7red and were identical to those that bound PAK pili (Fig. 3 
